Abstract: Alzheimer's disease (AD) is an aging-related multi-factorial disorder to which metabolic factors contribute at what has canonically been considered a centrally mediated process. Although the exact underlying mechanisms are still unknown, obesity is recognized as a risk factor for AD and the condition of insulin resistance seems to be the link between the two pathologies. Using mice with high fat diet (HFD) obesity we dissected the molecular mechanisms shared by the two disorders. Brains of HFD fed mice showed elevated levels of APP and Aβ 40 /Aβ 42 together with BACE, GSK3β and Tau proteins involved in APP processing and Aβ accumulation. Immunofluorescence, Thioflavin T staining experiments, confirmed increased Aβ generation, deposition in insoluble fraction and plaques formation in both the hippocampus and the cerebral cortex of HFD mice. Presence of Aβ 40 and Aβ 42 in the insoluble fraction was also shown by ELISA assay. Brain insulin resistance was demonstrated by reduced presence of insulin receptor (IRs) and defects in Akt-Foxo3a insulin signaling. We found reduced levels of phospho-Akt and increased levels of Foxo3a in the nuclei of neurons where proapototic genes were activated. Dysregulation of different genes related to insulin resistance, especially those involved in inflammation and adipocytokines synthesis were analyzed by Profiler PCR array. Further, HFD induced oxidative stress, mitochondrial dysfunction and dynamics as demonstrated by expression of biomarkers involved in these processes. Here, we provide evidence that obesity and AD markers besides insulin resistance are associated with inflammation, adipokine dyshomeostasis, oxidative stress and mitochondrial dysfunction, all mechanisms leading to neurodegeneration.
INTRODUCTION
Alzheimer's disease (AD) is a progressive neurodegenerative disease that is mainly diagnosed by its clinical features including progressive impairment of cognitive function, orientation, and motor activity, language disturbance, difficulty in recognizing or identifying objects and persons. Histopathological hallmarks of AD are the so-called senile plaques and neurofibrillary tangles obtained respectively by deposition of the aggregated β amyloid peptide (Aβ) and hyperphosphorylated Tau protein [1] . Aβ peptide derives from the sequential proteolytic cleavage of amyloid precursor protein (APP) by β-site APP cleaving enzyme 1 (BACE1) and γ−secretase, a multi-subunit protease complex comprised of proteins such as presenilin 1 or 2 (PS1, PS2) [1, 2] .
The prevalence of AD is progressively increasing in the world population. Thirty-five million people are now considered to be affected by AD and this number is expected to *Address correspondence to this author at the Institute of Biomedicine and Molecular Immunology CNR, via Ugo La Malfa 153, 90146 Palermo, Italy; Tel +390916809538; Fax +390916809548; E-mail: marta.dicarlo@ibim.cnr.it double in the next few decades [3] . In parallel, an increase in incidence of obesity has been observed during the last years [4] . In countries with a developed status the obesity is currently the most common nutritional disorder, with serious health-impairing consequences, not the least of which cognitive impairment [5] . In fact, some studies have reported that obesity is associated with reduced cognitive performance in humans [6, 7] as well as decreased brain volumes [8] and it is correlated with an increased probability of developing cognitive decline, including AD [9, 10] . According to Rotterdam studies, patients with obesity or other metabolic diseases, such as Type 2 Diabetes (T2D), have almost a twofold greatest risk of developing AD [11] .
Unfortunately, to date the precise mechanisms associating obesity to AD are unclear. In particular, specific molecular mechanism/s linking the pathophysiology of obesity to the brain alterations of AD remains poorly known. Different factors have been implicated, such as increased levels of APP in adipose tissue [12] and Aβ in plasma of obese individuals [13] and the presence of insulin resistance [5] . Indeed, numerous studies have indicated obesity as a factor which predisposes people to T2D and induces insulin resistance [14] . In fact, rates of T2D are more than double
Please provide corresponding author(s) photograph
amongst people who are obese. Insulin has a significant role in modulation of synaptic plasticity and learning memory [15, 16] . High concentrations of insulin are present in brain extracts and insulin receptors (IR) are highly expressed in brain regions that support memory formation, indicating that insulin may have a role in maintaining regular cognitive function [16] . Alterations in the concentration of insulin and insulin receptors in the brain have been reported in AD, leading some to consider AD as brain diabetes or ''Type 3 diabetes'' [17] . As such, irregularities in the insulin signaling pathway may contribute to impairment of memory function, comparable to those observed in patients with AD [18] . Moreover, animal and clinical studies have shown that intranasal administration of insulin improves cognitive behavior in mice, perhaps by modulating neuronal communication within the brain [19, 20] .
A high fat diet (HFD) is one of main factors that can promote obesity and previous studies have shown that such a diet can produce learning and memory impairments in rodents [21] [22] [23] [24] . HFD was previously shown to induce a remarkable brain insulin resistance as well as spatial memory impairment in a normal mouse or a transgenic model of AD [25] . However, whether the state of hyperinsulinemia in rodents can induce alterations in the central nervous system (CNS) remains controversial and observations seem to depend on the experimental approach to induce hyperinsulinemia and the specific tests performed [26] [27] [28] [29] . Therefore this study was undertaken in an attempt to understand the underlying mechanisms by which adipose tissue might influence cerebral structures related to learning and memory. With this view, we explored different points of molecular alterations present in the brains of C57BL6 mice fed HFD an animal model of diet-induced obesity and insulin resistance. In particular, we analyzed the effect of high fat diet intervention on brain metabolism, redox balance and mitochondrial homeostasis. In addition, the gene expression changes involved in the brain insulin resistance were analyzed.
MATERIAL AND METHODS

Mice
The experimental procedures employed in the present study were in accordance with the Italian D.L. no. 116 of 27 January 1992 and subsequent variations and the recommendations of the European Economic Community (86/609/ECC). The studies were approved by Ministero della Sanita` (Rome, Italy). Male C57BL/6J (B6) mice, purchased from Harlan Laboratories (San Pietro al Natisone Udine, Italy) at 4 weeks of age, were housed under standard conditions of light (12h light: 12h darkness cycle) and temperature (22-24°C) , with free access to water and food. After acclimatization (1 week), the animals were weighed and divided in two groups, which were fed a standard diet (STD) (4RF25, Mucedola, Milan, Italy), or fed for 23 weeks (7 months) a high fat diet (HFD) (PF4051/D, Mucedola) consisting of 23% protein, 38% carbohydrates, and 34% fat (60% caloric fat content), as previously described [30] . Animals were weighed and killed by cervical dislocation. The brains of age-matched animals were immediately exported, weighted and processed for subsequent analysis.
Glucose, Insulin and Insulin Tolerance Tests
Body weight, blood glucose and insulin levels were determined before sacrifice. Briefly blood glucose levels were measured from nicked tails using a glucometer (GlucoMen LX meter, Menarini, Italy). Quantification of plasma insulin was carried out by mouse enzyme-linked immunosorbent assay (Alpco Diagnostics, Salem, NH USA) according to the manufacturer's instructions. Insulin tolerance test (ITT) was carried out in mice fasted for 6 h with free access to water. Mice were given an i.p. injection of insulin (1.2 U/kg body weight) (Insuman Rapid, Sanofi Aventis, Italy) in 0.9% saline and plasma glucose was measured at different interval up to 120 min (0, 15, 30, 60, 90, 120).
Total Protein Extraction and Western Blotting
Brain of mice were homogenized in RIPA buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1 mM Na 3 VO 4 , 10 mM NaF, 1mM EDTA, 1 mM EGTA, 0.2 mM phenylmethylsulfonyl fluoride, 1% Triton, 0.1%SDS, and 0.5% deoxycholate) with protease inhibitors (Amersham) and phosphatase inhibitor cocktail II and III (SIGMA). To remove insoluble material tissue lysates were sonicated and centrifuged (14,000 rpm, at 4°C, for 30 min). Proteins (50 µg) were resolved by 10% SDS-PAGE gel and transferred onto nitrocellulose filters for Western blotting using anti-APP (1:1000), anti-Presenilin1 (1:1000), anti-p-ERK (1:1000), anti-heme-Oxygenase (1:500), anti-SOD2 (1:500), anti-Bad-2 (1:500), anti-VDAC1 (1:500), and anti-BACE1 (1:1000), anti-phospho-GSK-3β (Tyr216) (1:500) purchased from Santa Cruz, anti-IR (1:500), anti-GSK3α/β (1:1000), anti-i-NOS (1:500), anti-HSP60 (1:500), anti-FoxO3a (1:1000) and anti-phosphoFoxo3a (Ser253) (1:500) purchased from Cell Signaling, anti-AKT (1:1000), anti-phospho-Akt (Ser473) (1:500) purchased from Invitrogen, anti-phospho-Tau (Thr205) (1:200) purchased from Abcam, anti-β-actin (1:5000) purchased from Sigma. Secondary antibodies conjugated to horseradish peroxidase (1:2000) purchased from Cell Signaling were detected using the NOVEX ® ECL HRP chemiluminescence kit (Cat. n° WP20005, Invitrogen) according to the manufacturer's instructions. In some instances, antibodies were stripped from blots with Restore Western Blot Stripping Buffer (Thermo Scientific) for 10 minutes at room temperature, for antibody reprobing. Band intensities were analyzed with a gel documentation system (BioRad), expression was normalized with β-actin expression. The protein levels were expressed as densitometry and percentage of controls.
Preparation of Soluble and Insoluble Brain Fractions
Brain tissues were homogenated in ∼10 ml buffer/gram tissue in low salt buffer (LSB) (10 mM Tris, pH 7.5, 5 mM EDTA, 1 mM DTT, 10% (wt/vol) sucrose, Sigma protease inhibitor cocktail II and III). After centrifugation at 14,000 rpm for 30 min at 4°C, the supernatant was retained as soluble fraction and the pellet was resuspended in a detergent buffer (LSB plus 1% sarkosyl, N-Lauroylsarcosine and 0.5M NaCl). After brief sonication and centrifugation at 14,000 rpm for 50 min at room temperature, the supernatant was retained as detergent insoluble fraction. The soluble fraction and the detergent insoluble fraction were utilized for the ELISA assays. An enzyme-linked immunosorbent sandwich assay (ELISA) (Invitrogen) was performed for quantitative detection of mouse β-Amyloid (1-40) and in soluble and detergentin soluble brain fractions according to manufacturer's instructions.
Preparation of Cytoplasmic and Nuclear Protein Extracts
Nuclear and cytoplasmic extracts were prepared using NE-PER Nuclear and Cytoplasmic Extraction Reagents kit (Cat. n° 78833, Thermo Scientific) according to the manufacturer's instructions using buffers provided.
Immunomorphological Analyses: Immunohistochemistry and Immunofluorescence
For tissue preparation, brains from STD and HFD fed mice (n=3 per group) were harvested. The mice were sacrificed by cervical dislocation; the brains were removed, weighted and fixed in 4% formalin for 24h. The brains were embedded in paraffin and sectioned coronally (5µm) using a microtome. Brain sections including the hippocampus and cerebral cortex were mounted on superfrost plus tissue slides (Menzel-Gläser, Menzel-Glaser, Braunschweig, Germany) and deparaffinized. The slides were immersed in 0.3% H 2 O 2 for 5 min to quench endogenous peroxidase activity, and treated with 10 mM, pH 6.0, 0.05% Tween 20 tri-sodium citrate at 95°C for 8 min for antigen retrieval. Subsequently, immunohistochemistry was performed as previously described [31] using the Histostain-Plus IHC detection Kit (Histostain-plus Kit3rd Gen IHC Detection Kit, Life Technologies, Monza, Italy) according to the manufacturer's instructions. The sections were incubated with anti-APP (1:200) purchased from Santa Cruz and 3-3-diaminobenzidine (DAB chromogen solution, DAKO, Glostrup, Denmark) was used as developer chromogen. Nuclear counter staining was done using haematoxylin (DAKO). Appropriate positive and negative controls, were run concurrently. The slides were mounted with cover slips and images were taken with a Leica DM5000 upright microscope (Leica Microsystems, Heidelberg, Germany) at a magnification of 20X. For immunofluorescence sections were stained using the same primary antibody against APP used for immunohistochemistry (Santa Cruz, dilution 1:100) and with anti-IR (Cell Signaling, dilution 1:100) at 4°C overnight. After washing in PBS, the slides were incubated with anti-rabbit TRITC-conjugate and anti rabbit-FITC-coniugated secondary antibodies (SIGMA). Nuclear staining was performed using Hoechst 33258 (5µg/mL). For Thioflavin T (ThT) staining the brain slides were incubated with a 70 µM work solution for 10 minutes. The samples were analyzed by using a DHL fluorescent microscope (Leica Microsystems, Heidelberg, Germany) at a magnification of 20X. Fluorescence intensity was measured using Leica QFluoro program.
Quantitative Real-Time qPCR
Total RNA was extracted using RNeasy Lipid Tissue Mini Kit (Qiagen). Two ng of RNA was used to synthesize the first strand cDNA using RT First-Strand kit (Qiagen). Synthesized cDNAs were amplified using RT2 SYBR Green/ROX qPCR Mastermix (Qiagen) and StepOne RealTime instrument (Applied Biosystem). Gene expression validation was performed using home-made sequence primers for human APP, Foxo3a, Bim, Fas-Ligand, P27 and β-actin ( Table 1 ) or using commercial sequence primers listed in Table 2 (SABiosciences). Gene expression was normalized to β-actin. On the basis of the Ct value (threshold cyclethe number of reaction cycles after which fluorescence exceeds the defined threshold) of the examined gene and of the internal control gene the relative expression level of RNA was calculated according to the 2 -ΔΔCt approximation method.
RT2 ProfilerPCR Array
Mouse Insulin resistance (PAMM-156Z) focused pathway arrays (Insulin Resistance PCR Array, SABiosciences) in 96-well plate format were used to assay gene expression changes. Samples were prepared from pooled RNA extracted from STD and HFD mouse brains. Samples were added to the reaction plates following the manufacturer's instructions and and a StepOne Real-Time instrument (Applied Biosystem) was used to perform the array. Analysis was performed using the spreadsheet provided by SABiosciences.
Statistical Analysis
The results are presented as mean ± SD. Statistical evaluation was conducted by two-way ANOVA, followed by Student's t-test for analysis of significance. Results with a pvalue <0.05 were considered statistically significant, *P<0.05, **P<0.02. 
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3. RESULTS
Effects of HFD on Body and Brain Weights
In an effort to better understand the effect of high caloric diet on brain metabolism and risk of developing AD, C57BL6/J mice were fed with a high fat diet or a standard diet for seven months. Body and whole brain weights were measured (n=5 per group) at the time of sacrifice and the brain/body weight ratio was calculated. The HFD animals had a significantly higher weight, body weight relative to controls fed a standard diet. Moreover, the mean brain weights were lower in HFD than standard diet fed animals. However, the calculated mean brain/body weight ratio was significantly reduced in the HFD mice due to the combined effects of obesity and mild brain atrophy ( Table 3) . For the expression experiments we chose to utilize STD mice with a brain/body weight ratio > 0.01 (n=3 per group) and HFD mice with a brain/body weight ratio < 0.08 (n= 3 per group).
AD Markers Increase in Brains from HFD Versus Control Fed Mice
To examine whether HF feeding changed the expression levels of proteins with a well-established link to AD pathology such as APP, BACE, PSN1, total and active GSK3β and phosphorylated Tau, a Western blot of proteins extracted from brains of HFD and standard diet fed animals was performed (Fig. 1A,B) . Brain extracts from HFD mice revealed a significant increase in expression of APP and its cleavage peptides Aβ 40 and Aβ 42 compared to control diet fed mice. In agreement with this, an increase of BACE, an enzyme required for processing of APP to produce its pathogenic cleavage product Aβ, was observed, whereas no significant change was observed for PSN1. A substantial increase of GSK3β a protein involved in multiple processes such as Tau hyper-phosphorylation and Aβ production and mitochondrial dysfunction, was also detected. Furthermore, activation of GSK3β corresponded to an increase in Tau phosphorylation. Accordingly with protein levels observed, expression of APP mRNA, analyzed by quantitative real-time PCR (qRT-PCR), was significantly increased in HFD mice (Fig. 1C) . Furthermore, we visualized the presence of APP by immunofluorescence and immunohistochemistry experiments using coronary brain sections in which the hippocampus and cerebral cortex, two regions damaged in AD, were visible (Fig.  1D,E,F) . We observed increased immunoreactivity of APP in both the hippocampus and cortex of HFD mice compared to controls and some Aβ deposits were detected, indicating an increase in APP processing and aggregation of Aβ. Moreover, staining with Thioflavin T, a dye used to visualize the presence or fibrilization of misfolded protein aggregates, or amyloid plaques, demonstrated the presence of insoluble Aβ aggregates (Fig. 1G) . To confirm the presence of insoluble Aβ aggregates or amyloid plaques we utilized an anionic detergent to obtain a soluble and insoluble fraction from STD and HFD brain tissue. Increased levels of Aβ 40 and Aβ 42 aggregates were detected by ELISA assay in the deter- gent insoluble fraction with respect to soluble fraction (Fig.  1H) .
High Fat Diet Fed Mice Show Insulin Resistance
The HFD mice had significantly higher fasting plasma glucose levels ( Fig. 2A) and increased insulin (11.8 ± 3.5 ng/ml, n=5 P<0.01) compared to standard diet (0.8 ± 0.2 ng/ml; n=5) fed animals. Moreover, the ITT showed that in HFD mice the levels of blood glucose after intraperitoneal exogenous administration of insulin decreased less in comparison to standard diet fed animals ( Fig. 2A) , suggesting the presence of insulin resistance. This is also illustrated by the measurement of the glucose area under the curve (AUC) (Fig. 2B) . Insulin receptors were present on neurons in the brain and their reduced presence and activity was detectable in insulin resistance. Western blotting analysis revealed that brain levels of insulin receptor (IR) were decreased relative to controls (Fig. 2C,D) , confirming cerebral insulin resistance. Furthermore, immunofluorescence with anti-IR showed a reduced presence of these receptors in hippocampus from HFD fed mice compared to controls, confirming the metabolic data (Fig. 2E,F) . 
High Fat Diet Feeding Affects Insulin Signaling
To assess whether reduced IR presence compromises insulin signaling activation, a Western blot of total proteins extracted from brains of HFD and standard diet fed mice was incubated with antibodies against both the total and phosphorylated forms of Akt and Foxo3a. Decrease in Akt, posho-Akt and posho-Foxo3a levels and increase of Foxo3a were observed in HFD mice, indicating that the insulin signaling was affected (Fig. 3A,C) . Furthermore, we investigated about the subcellular localization of activated or unactivated forms of Akt and Foxo3a. In the nuclei of HFD mice, we observed a decrease in both Akt and phospho-Akt levels and a significant increase of Foxo3a (Fig. 3B,D,E) . In contrast, we found an increase in both phospho-Akt and Foxo3a and a decrease of phospho-Foxo3a in the cytoplasm. Moreover, by using quantitative Real Time PCR we confirmed that in the nuclei Foxo3a activates the expression of apoptotic genes such as FasL, Bim and p27. HFD fed mice showed an increase of mRNA levels of both Foxo3a and Bim, Fas-L and p27, compared to control mice (Fig. 3F) . Our results, as schematically shown in (Fig. 3G) , indicate that in STD condition phosphorylated Akt promotes Foxo3a export from the nucleus to the cytoplasm inhibiting its transcriptional activity. In contrast, in HFD condition, a decrease in phospho-Akt reduces Foxo3a phosphorylation and promotes its translocation to the nucleus where it activates transcription of its target genes (Fig. 3G) . Fig. (3) . HFD affects Akt/Foxo3a pathway. A) Western blot of brain lysates from STD and HFD fed mice incubated with anti-Akt, phosphoAkt (p-Akt), Foxo3a, phospho-Foxo3a (p-Foxo3a) and β-Actin (loading control) antibodies. B) Western blot of brain lysates from STD and HFD fed mice and subjected to subcellular fractionation in cytoplasmic (C) and nuclear (N) fractions and incubated with anti-Akt, phosphoAkt (p-Akt), Foxo3a, phospho-Foxo3a (p-Foxo3a), Lamin B (nuclear loading control) and β-Actin (cytoplasmic loading control) antibodies. C,D,E) Quantification of immunoreactivity was performed using densitometric analysis. F) Effect of HFD on Foxo3a, Bim, FasL, P27 transcript levels determined by quantitative real-time PCR. n= 3 per group. *P < 0.05,**P < 0.02 versus control group. G) Schematic representation of p27, Bim and FasL gene activation after high fat diet induced Foxo3a nuclear translocation.
HFD Affects Expression of Resistance Insulin Related Genes
To assess the expression changes in genes involved in insulin resistance in the brain we utilized a Profiler PCR array. Of the 84 genes, most of them were significantly differentially expressed. These genes and the relative fold changes respect to the control are listed in Supplementary file 1 (Fig.  S1 ). Among these, twelve were up-or down-regulated by more than 2 fold in HFD fed mice compared to the control (Fig. 4A) . In addition, we validated the expression of some of the most highly expressed genes that were associated with inflammation (Interferon γ, CD3 antigen, Chemokine Receptor 3, Chemokine receptor 4), adipokine signaling pathway (Adiponectin, Resistin, Leptin), and metabolism (Phosphoenolpyruvate carboxykinase, Pancreatic and duodenal homeobox 1), by quantitative real-time PCR (Fig. 4B,C) . As shown, the observed changes were always of the same order of magnitude as those obtained by PCR Arrays.
HFD Triggers Oxidative Stress and Mitochondrial Dysfunction
To evaluate whether there was a condition of oxidative stress in the brain of HFD fed mice, protein markers of stress such as phospho-ERK (p-ERK), inducible nitric oxide synthase (i-NOS), and antioxidant proteins such as superoxide dismutase 2 (SOD-2) and heme-oxigenase (H-Oxy), were analyzed by Western blotting. We found that the levels of p-ERK and i-NOS were significantly increased, whereas the levels of SOD-2 and H-Oxy were decreased, indicating that a condition of oxidative stress was present (Fig. 5A,B) . Similarly, we determined alterations of some proteins that are markers of mitochondrial dysfunction. By Western blotting in brain homogenates from HFD or STD fed mice we detected an increase of the levels of Bad-2 and voltagedependent anion channel (VDAC), mitochondrial matrix proteins, and a decrease of the levels of HSP60 indicating a condition of mitochondrial dysfunction (Fig. 6A,B) . This condition was confirmed by analysis of fission and fusion markers, mechanism involved in mitochondrial dynamics. By Real Time PCR an increase in mRNA levels of Drp1 and Fis1 and a decrease in mRNA levels of OPA1 and Mfn1, compared to control mice was revealed (Fig. 6C) , indicating that mitochondrial dynamics were perturbed in HFD fed mice.
DISCUSSION
Obesity is often associated with the consumption of a diet high in saturated fats, and several clinical/epidemiological studies have suggested this metabolic disease as a risk factor for the development of AD in later life [32, 33] . There is growing evidence to support the contribution of metabolic factors to this pathology, which have previously been considered limited to the central nervous system. However, the molecular mechanisms underlying this comorbidity, and the influence of high fat diet on cerebral structures, have not been well established. By use of a diet-induced obesity model, some of the molecules and pathogenic mechanisms shared by AD and this metabolic disorder were identified.
Increased body weight and reduced cerebral weight was found in HFD mice. Loss in brain mass and volume is a fea -Fig. (5) . Stress related proteins are modulated in high fat compared to standard diet fed mice. A) Western blot of protein brain lysates from STD and HFD fed mice was incubated with anti-phospho-ERK (p-ERK), i-NOS, H-Oxy, SOD2 antibodies.Uniformity of gel loading was confirmed with β-Actin as standard. B) Quantification of immunoreactivity was performed using densitometric analysis. n= 3 per group. *P < 0.05, **P < 0.02 versus control group. Fig. (6) . HFD impairs mitochondrial dynamics and induces mitochondrial dysfunction. A) Western blot of brain tissue lysates from STD and HFD fed mice probed with specific antibodies against Bad-2, VDAC, HSP60 mitochondrial proteins and β-Actin (general loading control). Arrow indicates bands of interest being present no specific bands. B) Quantification of immunoreactivity was performed using densitometric analysis. C) Effect of high fat versus standard diet on Fis1, Drp1, Opa and Mnf1 transcript levels determined by quantitative real-time PCR. n= 3 per group. *P < 0.05, **P < 0.02 versus control group. ture of AD and neuroimaging studies have indicated that disturbances in insulin metabolism, such as insulin resistance in obesity, T2D and AD, are linked to significant reduction of grey matter volume [34] . Moreover, studies using different diet compositions have demonstrated as high fat diet modulates levels of solubilized Aβ together with brain mass, density and volume [35] . Consistent with this result, we found that APP and certain proteins related to APP processing, including BACE1, are up-regulated in the brain of HDF fed mice. The increased presence of these proteins was associated with the increased production of Aβ40 and Aβ42. This explains the presence of insoluble Aβ fibrillar aggregates and amyloid plaques in hippocampal and cerebral cortex HFD brain sections, suggesting that neuronal network activity could be disturbed. Moreover, we found that activated GSK3β had induced Tau phosphorylation, a step necessary for its aggregation in the form of paired helical filaments and neurofibrillary tangles is a hallmark, with amyloid plaques, of AD.
There is evidence that elevated APP levels are present both in brain and adipose tissue of HFD fed animals supporting the hypothesis that APP expression could be coordinately regulated between brain and fat tissue [36] . Furthermore, a study, using diet-induced insulin resistance in Tg2576 mouse model of AD, has demonstrated that insulin resistance promoted an increase of Aβ peptide levels and early deposits, indicating that manipulation of diet could be a risk for AD [37] . Hence, monitoring of APP expression and processing in peripheral tissues could provide a checkpoint both for AD and obesity development and progression. Increase of APP gene expression may be correlated with insulin resistance and pro-inflammatory and adipocytokine gene expression [38, 39] . Insulin resistance, defined as a lower than expected response to a given dose of insulin, is a pathological condition characteristic of metabolic disorders as T2D, obesity and pathology related to aging [36] . Systemic insulin resistance refers to the state in which high levels of blood insulin (hyperinsulinemia) are associated with hyperglycemia. We found that peripheral and central insulin resistance coexists in HFD fed mice. In fact, HFD fed animals showed high fasting plasma glucose levels, increased insulin and reduced sensitivity to exogenous insulin, suggesting a state of peripheral insulin resistance, as previously shown [40] . At the molecular level, insulin resistance corresponds to a reduced number of IRs and impairment in insulin signaling, with reduced activation of specific pathways involved in metabolism and growth. High levels of IRs are present in healthy hippocampus, in contrast to the reduced levels that have been reported in patients with AD [17, 38] . In addition, studies using cultured neurons have demonstrated that IRs are redistributed or decreased in number under Aβ stimulation [41] [42] [43] . Our finding indicates that in the brains of HFD fed mice, the levels of IR are reduced, leading to compromisedinsulin signaling, as demonstrated by the analysis of Akt and Foxo3a expression and activation. When HFD is chronically ingested, Akt is down phosphorylated and Foxo3a translocates from the cytoplasm to the nucleus where it activates its proapototic target genes. Thus, impairment of insulin signaling induced by HFD can lead to neurodegeneration. Similarly, caloric restriction mediates, in TG2576 mice, activation of the insulin signaling pathway, leading to phosphorylation and exclusion of Foxo3a from the nucleus, and prevention of AD [44] . Furthermore, we cannot exclude that the consumption of a high fat diet has affected regulation of peripheral lipid metabolism, another factor which may be involved in brain insulin resistance. It has been hypothesized that peripheral insulin resistance may potentially cause brain insulin resistance via a liver-brain axis of neurodegeneration as a result of the trafficking of toxic lipids such as ceramides across the blood brain barrier (BBB) [36] .
Further evidence that obesity-induced insulin resistance may be a risk factor for AD onset and development derives from analysis of a specific array in which genes that are deregulated in this state were identified. Changes in levels of expression of genes involved in inflammation, innate immunity, insulin and adipokine signaling were detected. The highest differences in the profile of expression relative to controls were obtained for some of the genes involved in inflammation (up-regulated) and adipocytokine signaling (down-regulated), mechanisms present both in obesity and AD. Inflammation is part of the body's mechanism of defense against many challenges, and similar inflammatory processes are thought to occur in the brain and peripheral tissues [45, 46] . The presence of inflammatory markers such as cytokines/ chemokines and adipokines has been found in the AD brain and has been correlated with changes in the permeability of the BBB [47] . Generally, cytokines increase activity and expression of secretases, contributing to Aβ deposition and pathogenic changes in AD [48] . In particular, interferon γ, which produces pleiotropic effects in the brain, has been found to increase microglial activation and amyloid plaque formation in experimental models [49] . Thus, we cannot exclude that increased APP expression, processing and Aβ production could be correlated with the inflammatory changes induced by the high fat diet.
Leptin, adiponectin and resistin messengers are present in the brain, and their expression is dysregulated in our mouse model of diet-induced obesity. This modulation of adipocytokine messengers suggests that their presence in the brain is not exclusively related to peripheral production, and we cannot exclude a specific role in the central nervous system. Adipose tissue produces and releases into the systemic circulation adipocytokines which have metabolic, endocrine and anti-inflammatory functions. They can cross the BBB, and can therefore exert a neuroprotective role on cognitionrelated structures [50] . Consequently, dysfunction of adipocytokines related to obesity may increase the risk of AD. Leptin, beside its physiological action, shows beneficial effects on memory and consequent cognitive improvement when directly administrated to the hippocampal region [51] . In rodents, leptin plays a role in APP metabolism, by modulating secretase activity, Aβ peptide formation and clearance [52] . Leptin also seems to promote deactivation of GSK3β [53] , and reduced plasma levels of leptin have been associated with an increased risk of AD development [54] . In agreement with this result, we found reduced expression of leptin, activated GSK3β and phosphorylated Tau in the brains of HFD fed mice. Adiponectin is significantly downregulated in the brain of HFD fed mice where probably it is less able to exert its pro-anti-inflammatory action [55] . Two adiponectin receptors are present in hippocampal neurons, AdipoR1-2, and their neuroprotective role is mediated by activation of adenosine monophosphate-activated protein kinase (AMPK) [56] . Furthermore, adiponectin has been demonstrated to reduce Aβ-induced neurotoxicity, likely via inhibition of NF-κB. Our results are in agreement with the finding of decreased levels of circulating leptin and adiponectin in mild cognitive impairment and AD patients [57] . A protective effect of resistin against Aβ-induced neurotoxicity has been demonstrated in transgenic mice. Resistin attenuates levels of ROS, NO, protein carbonyls, improves mitochondrial function and prevents apoptosis by decreasing cytochrome c release [58] . Our data suggests that lower levels of adipocytokines may be the cause of the failure of their neuroprotective functioning, further evidence for the association between obesity and dementia.
Mitochondrial dysfunction and increased oxidative stress are both associated with obesity and AD. Upon high fat diet molecules involved in oxidative stress such as phosphorylated ERK, i-NOS and H-Oxy are up-regulated with respect to the control. This is in agreement with the common knowl-edge that inflammatory signals can induce oxidative imbalance and ROS production that can be mediated by stimulation of molecules such as i-NOS, which produces high levels of nitricoxide, facilitating the formation of other reactive oxygen and nitrogen species [59] . Similarly, markers of mitochondrial dysfunction change their expression in HFD. VDAC protein performs several functions in the mitochondrion, including maintenance of the mitochondrial permeability transition pore (PTP), regulating its shape and structure, and in apoptosis signaling [60] . Bcl-2 family members, such as Bad, regulate VDAC, leading to apoptogenic release of cytochrome c. Recent research has revealed that VDAC1 is increased in AD postmortem brains and in AD-affected brain tissues from AβPP transgenic mice. Additionally, other evidence have suggested that a progressive increase in interactions between VDAC1 and Aβ and phosphorylated Tau correlate with disease progression [61] . In contrast, a decrease of HSP60 levels was detected. This mitochondrial chaperonin is a ubiquitous molecule with multiple roles in health and disease [62, 63] recently found to be involved in insulin resistance [62] . HSP60 appears to be modulated by leptin in the hypothalamus of obese and diabetic mice and decreased levels of leptin were found in accordance with the reduced presence of HSP60 [64] . Decreased levels of leptin, as mentioned above, were found correlated with the reduced presence of Hsp60. Thus, the neuroprotective role of leptin via HSP60 is compromised in our model. An increase in mitochondrial fission (Fis1, Drp1) and decrease in fusion genes (OPA1, Mfn1) were found in HDF mice. Disordered mitochondrial dynamics are a feature of mitochondrial dysfunction and contribute to the pathogenesis of neurodegenerative diseases [65, 66] . Fission and fusion regulate fundamental cellular processes such as calcium homeostasis, ATP generation and ROS production. Unbalanced fusion leads to mitochondrial elongation and unbalanced fission leads to excessive mitochondrial fragmentation, both of which impair mitochondrial function. Moreover, recent studies have demonstrated that obesity and excess energy intake shift the balance of mitochondrial dynamics, contributing to mitochondrial dysfunction and metabolic deterioration all conditions leading to insulin resistance [67] .
CONCLUSION
This study supports the idea that the metabolic dysfunction leads to both in peripheral and central tissues, insulin resistance, a condition which contributes to inflammation, adypokine dysfunction, oxidative stress and mitochondrial dysfunction. These mechanisms affect each other through up-and down-regulation of specific molecules. In the brain, an insulin resistance status, may contribute to an increase in Aβ peptide levels and deposits, leading to neurodegeneration (Fig. 7) . Our findings suggest that preventing the cellular and metabolic dysfunctions common to both AD and obesity may not only attenuate pathological events in peripheral organs, but also those in the brain. Fig. (7) . A model of mechanisms that contribute and lead to peripheral insulin resistance in obesity and to brain insulin resistance in neurodegeneration. Inflammation, adypokine dysfunction, oxidative stress and mitochondrial dysfunction are interrelated through up-and downregulation of specific molecules.
